Osteoporosis in postmenopausal women
DOI:
https://doi.org/10.32385/rpmgf.v19i4.9958Keywords:
Osteoporosis, postmenopausal women, Risk Factors, fracturesAbstract
The osteoporosis in postmenopausal women is, in most cases of type I. Loss of bone mass is due to a deficiency of oestrogens. In the approach of osteoporosis in these women, it is important to consider the risk factors. To this end, a careful history and well prepared may lift the diagnosis of osteoporosis, since the clinic is usually poor or nonexistent until the first fracture appears. The secondary cause of osteoporosis should always be investigated, since all diagnostic and therapeutic approach will depend on the underlying cause. The diagnosis of osteoporosis is made primarily by the determination of bone mineral density, following the standards of the World Health Organization The treatment of osteoporosis in postmenopausal women, has the cornerstone prevent the appearance of cracks and passes through a non-pharmacological approach and, where necessary, pharmacology. The pharmacological treatment is particularly indicated for women with risk factors of fracture, or those who have already suffered breakage. In conclusion we present some proposed clinical approach to prevention and treatment of osteoporosis in women post - menopausal.Downloads
Downloads
Published
Issue
Section
License
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.